The Power of Innovation in Every Pulse
Since 2003, we have embarked on a path of innovation and medical breakthroughs, driven by a vision to transform the management of neurological illnesses.
Since developing the first non-invasive auricular vagus nerve stimulator, Cerbomed Nemos®, we now offer the most advanced tVNS® devices on the market, setting new standards in treatment efficacy, patient care and research.
Trusted by Leading Institutions Worldwide
A Legacy of Innovation
From our foundation in 2003 in Erlangen, Germany, our mission has been clear: to pioneer innovative treatments that redefine the treatment of neurological conditions.
The development of the Cerbomed Nemos® marked our first major leap into uncharted territories of medical technology, establishing us as pioneers in the field of non-invasive auricular vagus nerve stimulation and enabling thousands of Epilepsy patients to regain their quality of life and reduce seizures without medication or surgery.
In a market where ambitious claims often outpace results, we developed a device that genuinely improves patient outcomes, supported by a foundation of sound clinical evidence and proven effectiveness.
Engineering our tVNS® devices devices with efficacy at their core, we committed to an extensive research and development process, ensuring that every aspect of our technology was optimized for patient impact, addressing the complexities of neurological conditions with precision and reliability.
This paved the way for a landmark achievement: our new tVNS® E device became the first and only non-invasive vagus nerve stimulation stimulation device to be certified as a Class IIa medical device under the stringent criteria of the European Medical Device Regulation (MDR), underscoring our device’s efficacy and safety.
Leadership Team
Jörg Trinkwalter
Managing Director
Jörg Trinkwalter brings a wealth of experience and a broad network to tVNS Technologies as the head of business development. With a distinguished background as the former CEO and Co-Founder of Medical Valley, an influential MedTech cluster in the Nuremberg Metropolitan Region, he has a proven track record of fostering innovation and collaboration across startups, research institutions, and physicians. Prior to joining tVNS Technologies, Jörg played a pivotal role on the Management Team of Procarement, a MedTech startup specializing in cardiology. His philosophy at tVNS Technologies revolves around leveraging his extensive network and experience to bridge the gap between cutting-edge research and practical, impactful healthcare solutions, driving forward the mission to enhance patient care through technology.
Dipl-Ing. (FH) Tobias Jeglorz
CEO
Tobias Jeglorz brings over two decades of expertise in medical technology, engineering, and leadership. As CEO, his philosophy centers on fostering innovation through meticulous technical design and strategic vision. Tobias believes in creating medical solutions that not only push the boundaries of technology but also deeply resonate with and improve patient lives. His leadership style is a testament to the belief that true innovation arises from the intersection of advanced technology and genuine empathy for patient needs.
Why Choose tVNS®?
With its non-invasive approach, patient-friendly treatments, and minimal side effects, tVNS® offers a new horizon of hope and relief for those living with neurological conditions. Embrace a future where each day holds the promise of greater comfort and enhanced quality of life.
Certified Medical Device
tVNS® is the world's only non-invasive vagus nerve stimulation approved as a Class IIa medical device under the EU-MDR, offering a scientifically validated treatment for conditions related to sympathovagal imbalance.
Non-Invasive Approach
A safe and gentle alternative to surgery and medication, tVNS® stimulates the vagus nerve through the skin, offering a harmonious path to wellbeing with very low side-effects.
Control at Your Fingertips
Use our innovative tVNS® device anywhere and monitor your treatment through our user-friendly app. You have the freedom to tailor your therapy to your lifestyle.
Most Effective Stimulation Site
tVNS® is the only non-invasive stimulation device that stimulates the cymba concha, resulting in 100% vagus nerve innervation (as opposed to e.g. the tragus, which only results in 45% innervation).
Voices of Healing: Real Stories from tVNS® Patients
tVNS® in The Media
Our innovation projects are supported by the German Federal Ministry of Education and Research
Development and evaluation of a system for transcutaneous vagus nerve stimulation for depression in children and adolescents (tVNS-KJP)
Project Partner: Prof. Julian König, University Hospital Cologne
Needs-based vagus nerve stimulation for rehabilitation after stroke (BeVaReS)
Project Partner: Prof. Dr. Alireza Gharabagi, University Hospital Tübingen
Take the next step with tVNS® - for a life without limitations.
Get in Touch with Our Experts
Contact the tVNS® Team to learn more about tVNS® and receive personalized information and support, and begin your journey towards better health with tVNS®.
Your tVNS® Expert:
Elisa Hack
Directions to our Office
We warmly welcome visitors and in-person consultations at our office. Please contact our team to schedule your visit so we can ensure that you receive the best possible experience.